Long-term exposure to intranasal oxytocin in a mouse autism model

Translational Psychiatry

Volumn 4, Issue 11, 2014, Pages

  Bales, K L ^a,b   Solomon, M ^c   Jacob, S ^d   Crawley, J N ^c   Silverman, J L ^c   Larke, R H ^a,b   Sahagun, E ^a,b   Puhger, K R ^c   Pride, M C ^c   Mendoza, S P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; CLIMBING; CONDITIONING; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; GROOMING; HABITUATION; INBRED STRAIN; LEARNING; LONG TERM EXPOSURE; MALE; MEMORY; MOUSE; MOUSE MODEL; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; SELF CARE; SNIFFING; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; SOCIAL INTERACTION TEST; TASK PERFORMANCE; ANIMAL; ANIMAL BEHAVIOR; AUTISTIC DISORDER; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; HUMAN RELATION; INBRED MOUSE STRAIN; INTRANASAL DRUG ADMINISTRATION; SEX DIFFERENCE;

ADMINISTRATION, INTRANASAL; ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FEMALE; INTERPERSONAL RELATIONS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; OXYTOCIN; SEX FACTORS; SOCIAL BEHAVIOR;

EID: 84926077807     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.117     Document Type: Article

References (97)

1. Gimpl G, Fahrenholz F. The Oxytocin Receptor System: Structure, function, and regulation. Physiol Rev 2001; 81: 629-683.
2. Carter CS. Oxytocin pathways and the evolution of human behavior. Annu Rev Psychol 2014; 65: 17-39.
3. Zingg HH. Oxytocin. In: Pfaff, D, Arnold, AP, Etgen, AM, Fahrbach, SE, Rubin, RT (eds). Hormones, Brain, and Behavior, vol. 3. Academic Press: New York, NY, USA, 2002, pp 779-802.
4. Macdonald K, Feifel D. Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders. Front Neurosci 2013; 7: 35.
5. Guastella AJ, MacLeod C. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Horm Behav 2012; 61: 410-418.
6. Kumsta R, Heinrichs M. Oxytocin, stress and social behavior: neurogenetics of the human oxytocin system. Curr Opin Neurobiol 2013; 23: 11-16.
7. McCall C, Singer T. The animal and human neuroendocrinology of social cognition, motivation and behavior. Nat Neurosci 2012; 15: 681-688.
8. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature 2005; 435: 673-676.
9. Guastella AJ, Carson DS, Dadds MR, Mitchell PB, Cox RE. Does oxytocin influence the early detection of angry and happy faces? Psychoneuroendocrinology 2009; 34: 220-225.
10. Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC. Oxytocin improves "mindreading" in humans. Biol Psychiatry 2007; 61: 731-733.
11. Guastella AJ, Mitchell PB, Dadds MR. Oxytocin increases gaze to the eye region of human faces. Biol Psychiatry 2008; 63: 3-5.
12. Savaskan E, Ehrhardt R, Schulz A, Walter M, Schachinger H. Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 2008; 33: 368-374.
13. Rimmele U, Hediger K, Heinrichs M, Klaver P. Oxytocin makes a face in memory familiar. J Neurosci 2009; 29: 38-42.
14. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddanthi S et al. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 2005; 25: 11489-11493.
15. Domes G, Heinrichs M, Glascher J, Buchel C, Braus DF, Herpertz SC. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 2007; 62: 1187-1190.
16. Zink CF, Meyer-Lindenberg A. Human neuroimaging of oxytocin and vasopressin in social cognition. Horm Behav 2012; 61: 400-409.
17. De Dreu CK, Greer LL, Van Kleef GA, Shalvi S, Handgraaf MJ. Oxytocin promotes human ethnocentrism. Proc Natl Acad Sci 2011; 108: 1262-1266.
18. Shamay-Tsoory SG, Fischer M, Dvash J, Harari H, Perach-Bloom N, Levkovitz Y. Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biol Psychiatry 2009; 66: 864-870.
19. Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A et al. Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc Cogn Affect Neurosci 2010; 6: 556-563.
20. Goldman MB, Gomes AM, Carter CS, Lee R. Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Psychopharmacology 2011; 216: 101-110.
21. Olff M, Frijling JL, Kubzansky LD, Bradley B, Ellenbogen M.A, Cardoso C et al. The role of oxytocin in social bonding, stress regulation, and mental health: an update on the moderating effects of context and interindividual differences. Psychoneuroendocrinology 2013; 38: 1883-1894.
22. Bartz JA, Zaki J, Bolger N, Ochsner KN. Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 2011; 15: 301-309.
23. Bartz JA, Zaki J, Ochsner KN, Bolger N, Kolevzon A, Ludwig N et al. Effects of oxytocin on recollections of maternal care and closeness. Proc Natl Acad Sci 2010; 107: 21371-21375.
24. Bhandari R, van der Veen R, Parsons CE, Young KS, Voorthuis A, Bakermans-Kranenburg MJ et al. Effects of intranasal oxytocin administration on memory for infant cues: Moderation by childhood emotional maltreatment. Soc Neurosci 2014; 9: 536-547.
25. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 2003; 1: 193-198.
26. Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L et al. Oxytocin increases retention of social cognition in autism. Biol Psychiatry 2006; 61: 498-503.
27. Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 2010; 67: 692-694.
28. Andari E, Duhamel J-R, Zalla T, Herbrecht E, Leboyer M, Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci 2010; 107: 4389-4394.
29. Tachibana M, Kagitani-Shimono K, Mohri I, Yamamoto T, Sanefuji W, Nakimura A et al. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. J Child Adolesc Psychopharmacol 2013; 23: 123-127.
30. Kosaka H, Munesue T, Ishitobi M, Asano M, Omori M, Sato M et al. Long-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry 2012; 12: 110.
31. Dadds MR, MacDonald E, Cauchi AJ, Williams K, Levy F, Brennan J. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord 2014; 44: 521-531.
32. Anagnostou E, Soorya L, Brian J, Dupuis A, Mankad D, Smile S et al. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Res 2014; 1580: 188-198.
33. van Ijzendoorn MH, Bakersmans-Kranenburg MJ. A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group. Psychoneuroendocrinology 2012; 37: 438-443.
34. Bales KL, Perkeybile AM. Developmental experiences and the oxytocin receptor system. Horm Behav 2012; 61: 313-319.
35. Bales KL, Perkeybile AM, Conley OG, Lee MH, Guoynes CD, Downing GM et al. Chronic intranasal oxytocin causes long-term impairment in partner preference formation in male prairie voles. Biol Psychiatry 2013; 74: 180-188.
36. Huang H, Michetti C, Busnelli M, Manago F, Sannino S, Scheggia E et al. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology 2014; 39: 1102-1114.
37. Berridge KC, Aldridge JW, Houchard KR, Zhuang X. Sequential superstereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive-compulsive disorder and Tourette's. BMC Biol 2005; 3: 4.
38. Peters S, Slattery DA, Uschold-Schmidt N, Reber SO, Neumann ID. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology 2014; 42: 225-236.
39. Altemus M, Redwine LS, Leong YM, Frye CA, Porges SW, Carter CS. Responses to laboratory psychosocial stress in postpartum women. Psychosom Med 2001; 63: 814-821.
40. Amico JA, Mantella RC, Vollmer RR, Li X. Anxiety and stress responses in female oxytocin deficient mice. J Neuroendocrinol 2004; 78: 333-339.
41. Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M et al. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010; 35: 2403-2413.
42. Chini B, Leonzino M, Braida D, Sala M. Learning about oxytocin: pharmacologic and behavioral issues. Biol Psychiatry 2013; 76: 360-366.
43. Vannucchi G, Masi G, Dell'Osso L, Marazziti D, Perugi G. Clinical features, developmental course, and psychiatric comorbidity of adult autism spectrum disorders. CNS Spectr 2014; 19: 157-164.
44. South M, Larson MJ, White SE, Dana J, Crowley MJ. Better fear conditioning is associated with reduced symptom severity in autism spectrum disorders. Autism Res 2011; 4: 412-421.
45. Toth I, Neumann ID, Slattery DA. Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepointdependent manner. Psychopharmacology 2012; 223: 149-158.
46. Lahoud N, Maroun M. Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquistion and extinction. Psychoneuroendocrinology 2013; 38: 2184-2195.
47. Acheson D, Feifel D, de Wilde S, Mckinney R, Lohr J, Risbrough V. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology 2013; 229: 199-208.
48. Yang M, Zhodzishsky V, Crawley JN. Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. Int J Dev Neurosci 2007; 25: 515-521.
49. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007; 176: 4-20.
50. Silverman JL, Smith DG, Sukoff Rizzo SJ, Karras MN, Turner SM, Tolu SS et al. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med 2012; 4: 131ra151.
51. McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN. Autism-like phenotypes in BTBR T+tf/J mice. Genes Brain Behav 2008; 7: 152-163.
52. Yang M, Abrams DN, Zhang JY, Weber MD, Katz AM, Clarke AM et al. Low sociability in BTBR T+tf/J mice is independent of partner strain. Physiol Behav 2012; 107: 649-662.
53. Yang M, Perry K, Weber MD, Katz AM, Crawley JN. Social peers rescue autismrelevant sociability deficits in adolescent mice. Autism Res 2011; 4: 17-27.
54. Rutz HL, Rothblat LA. Intact and impaired executive abilities in the BTBR mouse model of autism. Behav Brain Res 2012; 234: 33-37.
55. Silverman JL, Gastrell PT, Karras MN, Solomon M, Crawley JN. Cognitive abilities on transitive inference using a novel touchscreen technology for mice. Cereb Cortex 2013 (e-pub ahead of print).
56. Pearson BL, Pobbe RLH, Defensor EB, Oasay L, Bolivar VJ, Blanchard DC et al. Motor and cognitive stereotypics in the BTBR T+tf/J mouse model of autism. Genes Brain Behav 2011; 10: 228-235.
57. Bolivar VJ, Walters SR, Phoenix JL. Assessing autism-like behavior in mice: variations in social interactions among inbred strains. Behav Brain Res 2007; 176: 21-26.
58. Pobbe RL, Pearson BL, Defensor EB, Bolivar VJ, Blanchard DC, Blanchard RJ. Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behav Brain Res 2010; 214: 443-449.
59. Francis SM, Sagar A, Levin-Decanini T, Liu W, Carter CS, Jacob S. Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders. Brain Res 2014; 1580: 199-218.
60. Carter CS. Developmental consequences of oxytocin. Physiol Behav 2003; 79: 383-397.
61. Carter CS. Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? Behav Brain Res 2007; 176: 170-186.
62. Bakermans-Kranenburg MJ, Van Ijzendoorn MH. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry 2013; 3: e258.
63. Ditzen B, Schaer M, Gabriel B, Bodenmann G, Ehlert U, Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry 2009; 65: 728-731.
64. Domes G, Heinrichs M, Kumbier E, Grossmann A, Hauenstein K, Herpertz SC. Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder. Biol Psychiatry 2013; 74: 164-171.
65. Prehn K, Kazzer P, Lischke A, Heinrichs M, Herpertz SC, Domes G. Effects of intranasal oxytocin on pupil dilation indicate increased salience of socioaffective stimuli. Psychophysiology 2013; 50: 528-537.
66. Neumann ID, Maloumby R, Beiderbeck DI, Lukas M, Landgraf R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 2013; 38: 1985-1993.
67. Yang M, Bozdagi O, Scattoni ML, Wohr M, Roullet FI, Katz AM et al. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci 2012; 32: 6525-6541.
68. Chadman KK, Gong S, Scattoni ML, Boltuck SE, Gandhy SU, Heintz N et al. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res 2008; 1: 147-158.
69. Silverman JL, Turner SM, Barkan CL, Tolu SS, Saxena R, Hung AY et al. Sociability and motor functions in Shank1 mutant mice. Brain Res 2011; 1380: 120-137.
70. Yang M, Crawley JN. Simple behavioral assessment of mouse olfaction. Curr Protoc Neurosci 2009; Chapter 8: Unit 8.24.
71. Silverman JL, Yang M, Turner SM, Katz AM, Bell DB, Koenig JI et al. Low stress reactivity and neuroendocrine factors in the BTBR T+tf/J mouse model of autism. Neuroscience 2010; 171: 1197-1208.
72. Brielmaier J, Senerth JM, Silverman JL, Matteson PG, Millinog JH, DiCicco-Bloom E et al. Chronic desipramine treatment rescues depression-related, social and cognitive deficits in Engrailed-2 knockout mice. Genes Brain Behav 2014; 13: 286-298.
73. Uvnas-Moberg K. Oxytocin may mediate the benefits of positive social interactions and emotions. Psychoneuroendocrinology 1998; 23: 819-835.
74. Dunbar RIM. The social role of touch in humans and primates: Behavioural function and neurobiological mechanisms. Neurosci Biobehav Rev 2010; 34: 260-268.
75. Stapley NW, Guariglia SR, Chadman KK. Cued and contextual fear conditioning in BTBR mice is improved with training or atomoxetine. Neurosci Lett 2013; 549: 120-124.
76. MacPherson P, McGaffigan R, Wahlsten D, Nguyen PV. Impaired fear memory, altered object memory and modified hippocampal synaptic plasticity in splitbrain mice. Brain Res 2008; 1210: 179-188.
77. Williams JR, Insel TR, Harbaugh CR, Carter CS. Oxytocin centrally administered facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J Neuroendocrinol 1994; 6: 247-250.
78. Cho MM, DeVries AC, Williams JR, Carter CS. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav Neurosci 1999; 113: 1071-1079.
79. Bales KL, Kim AJ, Lewis-Reese AD, Carter CS. Both oxytocin and vasopressin may influence alloparental behavior in male prairie voles. Horm Behav 2004; 45: 354-361.
80. Cushing BS, Carter CS. Peripheral pulses of oxytocin increase partner preferences in female, but not male, prairie voles. Horm Behav 2000; 37: 49-56.
81. Lukas M, Toth I, Reber SO, Slattery DA, Veenema AH, Neumann ID. The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 2011; 36: 2159-2168.
82. Young LJ, Lim MM, Gingrich B, Insel TR. Cellular mechanisms of social attachment. Horm Behav 2001; 40: 133-138.
83. Teng BL, Nonneman RJ, Agster KL, Nikolova VD, Davis TT, Riddick NV et al. Prosocial effects of oxytocin in two mouse models of autism spectrum disorders. Neuropharmacology 2013; 72: 187-196.
84. Ahern TH, Young LJ. The impact of early life family structure on adult social attachment, alloparental behavior, and the neuropeptide systems regulating affiliative behaviors in the monogamous prairie vole (Microtus ochrogaster). Front Behav Neurosci 2009; 3: 17.
85. Curley JP, Davidson S, Bateson P, Champagne FA. Social enrichment during postnatal development induces transgenerational effects on emotional and reproductive behavior in mice. Front Behav Neurosci 2009; 3: 1-14.
86. Weisman O, Zagoory-Sharon O, Feldman R. Oxytocin adminsitration to parent enhances infant physiological and behavioral readiness for social engagement. Biol Psychiatry 2012; 72: 982-989.
87. Pobbe RLH, Defensor EB, Pearson BL, Bolivar VJ, Blanchard DC, Blanchard RJ. General and social anxiety in the BTBR T+tf/J mouse strain. Behav Brain Res 2011; 216: 446-451.
88. Poirier GL, Imamura N, Zanoletti O, Sandi C. Social deficits induced by peripubertal stress in rats are reversed by resveratrol. J Psychiatr Res 2014; 57: 157-164.
89. Tsuda MC, Ogawa S. Long-lasting consequences of neonatal maternal separation on social behaviors in ovariectomized female mice. PLoS One 2012; 7: e33028.
90. Trainor BC, Pride MC, Villalon Landeros R, Knoblauch NW, Takahashi EY, Silva AL et al. Sex differences in social interaction behavior following social defeat stress in the monogamous California mouse (Peromyscus californicus). PLoS One 2011; 6: e17405.
91. Saavedra-Rodriguez L, Feig LA. Chronic social instability induces anxiety and defective social interactions across generations. Biol Psychiatry 2013; 73: 44-53.
92. Benno R, Smirnova Y, Vera S, Liggett A, Schanz N. Exaggerated responses to stress in the BTBR T+tf/J mouse: an unusual behavioral phenotype. Behav Brain Res 2009; 197: 462-465.
93. Bales KL, Lewis-Reese AD, Pfeifer LA, Kramer KM, Carter CS. Early experience affects the traits of monogamy in a sexually dimorphic manner. Dev Psychobiol 2007; 49: 335-342.
94. Bales KL, Boone E, Epperson P, Hoffman G, Carter CS. Are behavioral effects of early experience mediated by oxytocin? Front Psychiatry 2011; 2: 24.
95. Preti A, Melis M, Siddi S, Vellante M, Doneddu G, Fadda R. Oxytocin and autism: a systematic review of randomized controlled trials. J Child Adolesc Psychopharmacol 2014; 24: 54-68.
96. Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 2009; 34: 917-923.
97. Einfeld SL, Smith E, McGregor IS, Steinbeck K, Taffe J, Rice LJ et al. A double-blind randomized control trial of oxytocin nasal spray in Prader Willi syndrome. Am J Med Genet A 2014; 164A: 2232-2239.